Literature DB >> 34294523

The TRIANGLE operation for pancreatic head and body cancers: early postoperative outcomes.

Rosa Klotz1, Thilo Hackert2, Patrick Heger1, Pascal Probst1, Ulf Hinz2, Martin Loos2, Christoph Berchtold2, Arianeb Mehrabi2, Martin Schneider2, Beat P Müller-Stich2, Oliver Strobel2, Markus K Diener1, André L Mihaljevic1, Markus W Büchler3.   

Abstract

BACKGROUND: Surgical resection is the mainstay of potential cure for patients with pancreatic cancer, however, local recurrence is frequent. Previously, we have described an extended resection technique for pancreatoduodenectomy aiming at a radical resection of the nerve and lymphatic tissue between celiac artery, superior mesenteric artery and mesenteric-portal axis (TRIANGLE operation). Until now, data on postoperative outcome have not been reported, yet.
METHODS: Patients who underwent either partial (PD) or total pancreatoduodenectomy (TP) applying the TRIANGLE procedure were identified. These cohorts were compared to matched historic cohorts with standard resections.
RESULTS: Overall, 330 patients were analysed (PDTRIANGLE and PDSTANDARD, each n = 108; TPTRIANGLE and TPSTANDARD, each n = 57). More lymph nodes were harvested in TRIANGLE compared to standard resection (PD: 27.5 (21-35) versus 31.5 (24-40); P = 0.0187, TP: 33 (28-49) versus 44 (29-53); P = 0.3174) and the rate of tumour positive resections margins, R1(direct), dropped. Duration of operation was significantly longer and blood loss higher. Postoperative mortality and complications did not differ significantly.
CONCLUSION: Pancreatoduodenectomy according to the TRIANGLE protocol can be performed without increased morbidity and mortality at a high-volume centre. Long-term survival and quality of life need to be investigated in prospective clinical trials with adequate sample size.
Copyright © 2021 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34294523     DOI: 10.1016/j.hpb.2021.06.432

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  2 in total

1.  Surgical Oncology: Multidisciplinarity to Improve Cancer Treatment and Outcomes.

Authors:  Jörg Kleeff; Ulrich Ronellenfitsch
Journal:  Curr Oncol       Date:  2021-11-04       Impact factor: 3.677

Review 2.  State-of-the-art surgery for pancreatic cancer.

Authors:  Anna Nießen; Thilo Hackert
Journal:  Langenbecks Arch Surg       Date:  2021-11-09       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.